CD83 and lung carcinoma: As shown in Fig 2A, the transfer of DC-based HHP lung cancer vaccine into serum containing conditions led to an increased expression of CD80 and CD83 within next 24 h compared to DC-based HHP lung cancer vaccine left in serum-free medium.